Curai Health Collaborates with UMass Chan Medical School
In an innovative partnership, Curai Health has joined forces with UMass Chan Medical School to bring virtual care to participants in a groundbreaking study focused on COVID-19 testing methodologies. This initiative explores the efficacy of at-home antigen and molecular tests compared to traditional lab-based PCR tests in identifying current variants of SARS-CoV-2, as well as influenza A and B viruses.
Free Virtual Care for Study Participants
The study offers free virtual care visits for adult participants who receive positive COVID-19 or flu tests. By connecting these individuals with medical professionals through Curai Health, they gain access to necessary care not only for COVID-19 and flu but for other medical needs as well.
Quotes from Curai Leadership
Neal Khosla, CEO and co-founder of Curai Health, emphasized the importance of this collaboration, stating, "The pandemic significantly reshaped our expectations regarding at-home testing and virtual healthcare. However, there's still confusion surrounding the steps to take upon receiving a positive COVID-19 test. Our partnership with UMass Chan enables us to provide participants with convenient, high-quality care right at home."
Focus of the STOP COVID-19 Research Study
The UMass Self-Testing for Our Protection from COVID-19 (STOP COVID-19) Research Study, which has received funding from the National Institutes of Health, aims to gather crucial insights regarding the performance of rapid antigen tests against PCR tests following symptom onset. Participants in this study will enroll for a duration of up to 16 weeks, using home-based antigen tests, while also collecting samples for PCR testing after symptoms develop. An innovative aspect involves participants logging symptoms into a virtual diary and sharing their experiences using an app called MyDataHelps, which is supported by Care Evolution, LLC.
Importance of Timely Clinical Care
Dr. Apurv Soni, assistant professor of medicine and co-director of the Program in Digital Medicine at UMass Chan Medical School, pointed out the critical link between at-home testing and clinical care. He stated, "While improving at-home testing for COVID-19 is crucial, it must be coupled with clinical care access. These respiratory viruses pose significant health risks, and quick clinician access for appropriate treatment is vital, particularly for isolated patients."
Curai Health's Approach to Virtual Care
As a leader in integrating machine learning into clinical workflows, Curai Health works alongside health plans and systems to maintain patient engagement throughout their care journey, ultimately enhancing health outcomes and minimizing costs. Established in 2017, Curai Health has made strides in providing on-demand, affordable, high-quality virtual care that meets the growing demand. By harnessing AI capabilities, the company supports teams of licensed clinicians, thereby delivering care that pushes beyond traditional limits.
About Curai Health
Curai Health is dedicated to transforming access to affordable, high-quality healthcare through AI-powered virtual clinics. By partnering with insurers and health systems, Curai ensures that patients remain engaged in their healthcare over time, which benefits their health outcomes and reduces costs. Since its inception, the organization has attracted prominent investors such as Morningside Ventures, General Catalyst, and Khosla Ventures, continually seeking to enhance the intersection of clinician expertise with AI efficiencies.
About UMass Chan Medical School
UMass Chan Medical School is integral to the University of Massachusetts system, comprising essential schools dedicated to advancing medicine, biomedical sciences, nursing, and public health consulting. As a top-ranked institution for primary care education and biomedical research, UMass Chan remains committed to improving health and wellness in diverse communities through its innovative programs.
Frequently Asked Questions
What is the focus of the Curai Health and UMass Chan collaboration?
This partnership aims to provide virtual care for participants involved in a COVID-19 study, focusing on comparing at-home testing methods with lab-based tests.
How can study participants access care?
Participants who test positive for COVID-19 or the flu can utilize free virtual care visits with Curai Health.
What technology supports participant symptom tracking?
Participants log their symptoms through a virtual diary using the MyDataHelps app, which is backed by Care Evolution, LLC.
Why is timely clinical care important in this study?
Timely access to clinical care allows for appropriate treatment, ensuring better outcomes for patients dealing with severe respiratory viruses.
What role does machine learning play in Curai Health's services?
Curai Health utilizes machine learning to streamline clinical workflows, enhancing patient engagement and improving healthcare delivery efficiency.
